CytomX Therapeutics Inc (NASDAQ:CTMX) has a beta value of 2.12 and has seen 1.51 million shares traded in the last trading session. The company, currently valued at $417.50M, closed the last trade at $2.65 per share which meant it gained $0.14 on the day or 5.58% during that session. The CTMX stock price is -6.42% off its 52-week high price of $2.82 and 84.91% above the 52-week low of $0.40.
The consensus among analysts is that CytomX Therapeutics Inc (CTMX) is Buy stock at the moment, with a recommendation rating of 1.50. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 4 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
CytomX Therapeutics Inc (NASDAQ:CTMX) trade information
Over the past 30 days, the shares of CytomX Therapeutics Inc (NASDAQ:CTMX) have changed 230.42%.
Wall Street analysts have a consensus price target for the stock at $5.84, which means that the shares’ value could jump 54.62% from current levels. The projected low price target is $3.25 while the price target rests at a high of $8.0. In that case, then, we find that the current price level is -201.89% off the targeted high while a plunge would see the stock gain -22.64% from current levels.
CytomX Therapeutics Inc (CTMX) estimates and forecasts
The company’s shares have gained 159.80% over the past 6 months.
CTMX Dividends
CytomX Therapeutics Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
CytomX Therapeutics Inc (NASDAQ:CTMX)’s Major holders
The top two institutional holders are TANG CAPITAL MANAGEMENT LLC with over 7.79 million shares worth more than $9.51 million. As of 2024-06-30, TANG CAPITAL MANAGEMENT LLC held 9.1799% of shares outstanding.
The other major institutional holder is JANUS HENDERSON GROUP PLC, with the holding of over 6.3 million shares as of 2024-06-30. The firm’s total holdings are worth over $7.72 million and represent 7.4245% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 3.05% shares in the company for having 2.46 shares of worth $6.51 million while later fund manager owns 981.49 shares of worth $2.6 million as of Mar 31, 2025 , which makes it owner of about 1.22% of company’s outstanding stock.
